Clinical trials
Recruiting Phase 3 Recurrence trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 10 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AVEO Pharmaceuticals, Inc. | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| AstraZeneca | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Celgene | 1 |
| Chengdu Zenitar Biomedical Technology Co., Ltd | 1 |
| Chinese Academy of Medical Sciences | 1 |
| Chinese PLA General Hospital | 1 |
| Chipscreen Biosciences, Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 35 |
| Multiple Myeloma | 6 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Nasopharyngeal Carcinoma | 2 |
| Ovarian Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Bulbo-Spinal Atrophy, X-Linked | 1 |
| Burkitt Lymphoma | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.